ro5323441
mAbexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started May 1, 2010 (NCT01148758)
Timeline
2010s
- Jan 1, 2010
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Placenta growth factorINHIBITOR
PGF inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ro5323441
- ro5323441
- tb-403 monoclonal antibody
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01308684 | Phase 1 | May 1, 2011 | Roche |
| NCT01308723 | Phase 1 | Mar 1, 2011 | Roche |
| NCT01148758 | Phase 1 | May 1, 2010 | Roche |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Roche | For profit | 3 | 3 | 1 | 2010 |
1 organizations
Page 1 / 1